Risk Factors for Genital and Anal Warts in a Prospective Cohort of HIV-Negative Homosexual Men: The HIM Study
- 1 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 34 (7) , 488-493
- https://doi.org/10.1097/01.olq.0000245960.52668.e5
Abstract
Objective: The objective of this study was to determine the prevalence, incidence, and risk factors for genital and anal warts in HIV-negative homosexual men in Sydney. Study Design: The authors conducted a prospective cohort study. Participants were asked whether they had had genital and anal warts at each interview. Details of lifetime sexual contacts and sexual behaviors in the last 6 months were collected. Results: Among 1,427 men recruited, 8.9% and 19.6% reported a history of genital and anal warts at baseline, respectively. Incidence rates for genital and anal warts were 0.94 and 1.92 per 100 person-years, respectively. In multivariate analysis, both incident genital and anal warts were associated with younger age. In addition, incident genital warts was associated with insertive fingering (P trend = 0.018), whereas incident anal warts was associated with insertive fingering (P trend = 0.007) and insertive fisting (P trend = 0.039). Conclusions: Anal warts were twice as common as genital warts. Fingering and other manual sexual practices may be an important transmission route for both.Keywords
This publication has 24 references indexed in Scilit:
- Transmission of Herpes Simplex Virus Types 1 and 2 in a Prospective Cohort of HIV‐Negative Gay Men: The Health in Men StudyThe Journal of Infectious Diseases, 2006
- Genital human papillomavirus infection in menThe Lancet Infectious Diseases, 2006
- Determinants of genital wart case detection rates among STD clinic attendees in Athens, GreeceInternational Journal of Dermatology, 2005
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialThe Lancet Oncology, 2005
- Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the USPharmacoEconomics, 2005
- Age‐Specific Prevalence of Anal Human Papillomavirus Infection in HIV‐Negative Sexually Active Men Who Have Sex with Men: The EXPLORE StudyThe Journal of Infectious Diseases, 2004
- Sex in Australia: Sexually transmissible infection and blood‐borne virus history in a representative sample of adultsAustralian and New Zealand Journal of Public Health, 2003
- Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle VaccineJournal of Virology, 2002
- Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United StatesSexually Transmitted Diseases, 1999
- Prevalence and Risk Factors for Human Papillomavirus Infection of the Anal Canal in Human Immunodeficiency Virus (HIV)‐Positive and HIV‐Negative Homosexual MenThe Journal of Infectious Diseases, 1998